Connecticut Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Connecticut Health Digest.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 20, 2026

an hour ago

AlayaCare and Eitan Medical partner to eliminate manual transcription for home infusion nurses

GlobeNewswire

an hour ago

Baba Appoints Former Mount Sinai Executive Director to Lead Clinical Operations

GlobeNewswire

an hour ago

ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform

GlobeNewswire

an hour ago

BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform

GlobeNewswire

an hour ago

Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care

GlobeNewswire

an hour ago

HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc.

GlobeNewswire

an hour ago

AVIS À IGNORER -- BVI Medical, Inc.

GlobeNewswire

2 hours ago

$3.2+ BN Medical Radiation Shielding Market Forecasts to 2034: Rising More Imaging and Therapy Procedures Due to Growing Chronic Diseases and Increasing Risk Awareness

GlobeNewswire

2 hours ago

Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc.

GlobeNewswire

2 hours ago

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

GlobeNewswire

2 hours ago

First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases

GlobeNewswire

2 hours ago

Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results

GlobeNewswire

2 hours ago

Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA

GlobeNewswire

2 hours ago

Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa

GlobeNewswire

2 hours ago

Rpharmy Completes SOC 2® Type II Audit, Reinforcing Its Commitment to Data Security in Healthcare

GlobeNewswire

2 hours ago

Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond

GlobeNewswire

2 hours ago

Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

GlobeNewswire

2 hours ago

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

GlobeNewswire

2 hours ago

Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

GlobeNewswire

2 hours ago

Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics

GlobeNewswire